Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study

BACKGROUND AND OBJECTIVES: In the CaLIPSO study, intravenous administration of SNF472 (300 or 600 mg) during hemodialysis significantly attenuated progression of coronary artery and aortic valve calcification. SNF472 selectively inhibits formation of hydroxyapatite, the final step in cardiovascular...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin J Am Soc Nephrol
Egile Nagusiak: Bushinsky, David A., Raggi, Paolo, Bover, Jordi, Ketteler, Markus, Bellasi, Antonio, Rodriguez, Mariano, Sinha, Smeeta, Garg, Rekha, Perelló, Joan, Gold, Alex, Chertow, Glenn M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2021
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8259477/
https://ncbi.nlm.nih.gov/pubmed/33835939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.16931020
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak